Change in management The board of directors and CEO/CFO Anders Fink Vadsholt has today entered into a severance agreement pursuant to which...
Major shareholder announcement Company announcement No. 10/2023 Orphazyme A/S Ole Maaløes Vej 3DK-2200 Copenhagen N ...
Major shareholder announcement Company announcement Orphazyme A/SNo. 09/2023 Ole Maaløes Vej 3DK-2200 Copenhagen N...
Resolutions passed at the Annual General Meeting Company announcement ...
Changes to the Board of Directors Company announcement ...
Major shareholder announcement Company announcement ...
Major shareholder announcement Company announcement Orp...
Notice to convene Annual General Meeting Company announcement Orphazyme A/SNo. 03/2023Ole...
Orphazyme Announces Publication of 2022 Financial Results and Annual Report Company announcement ...
Change to Financial Calendar for 2023 and update regarding class action lawsuit in United States Company announcement ...
Orphazyme reports financial results in Interim Report First Half 2022 Company announcementOrphazyme A/SNo. 36/2022 ...
Adjusted financial outlook for 2022 Orphazyme A/SCompany announcement No. 35/2022 www.orphazyme.comCompany...
Updated financial calendar for 2022 Company announcement Orphazyme A/SNo. 34/2022 www.orphazyme.comCompany Registration No. 32266355...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.